Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,708.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 2,774.00p
  • 52 Week Low: 1,637.00p
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 12,580
  • Market Cap: £1,127.82m
  • RiskGrade: 128

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
16-May-23 Peel Hunt Limited Buy 2,544.00p - 4,500.00p Reiteration
07-Dec-21 Liberum Capital Buy 4,948.00p - 5,740.00p Reiteration
29-Jun-21 Citigroup Hold 4,972.00p 5,500.00p 5,500.00p Reiteration
29-Jun-21 Numis Add 4,972.00p - 5,500.00p Reiteration
06-Dec-18 Kepler Capital Markets Buy 2,386.00p 2,475.00p 2,630.00p Upgrade
01-Mar-18 Berenberg Bank Hold 2,200.00p 1,800.00p 1,800.00p Reiteration
30-Oct-17 N 1 Singer Buy 2,430.00p 1,844.00p 2,485.00p Upgrade
04-Aug-16 HSBC Buy 1,907.00p - 2,200.00p Reiteration
12-May-15 Numis Securities Hold 1,388.00p - 1,410.00p Reiteration
01-Apr-14 Panmure Gordon Sell 985.50p 1,055.00p 910.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Genus Market Data

Currency UK Pounds
Share Price 1,708.00p
Change Today 4.00p
% Change 0.23 %
52 Week High 2,774.00p
52 Week Low 1,637.00p
Volume 12,580
Shares Issued 66.03m
Market Cap £1,127.82m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.12% below the market average95.12% below the market average95.12% below the market average95.12% below the market average95.12% below the market average
96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average
Price Trend
62.02% below the market average62.02% below the market average62.02% below the market average62.02% below the market average62.02% below the market average
22.81% above the sector average22.81% above the sector average22.81% above the sector average22.81% above the sector average22.81% above the sector average
Income
84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 26-Apr-2024

Time Volume / Share Price
13:35 38 @ 1,708.00p
13:30 25 @ 1,712.00p
13:30 25 @ 1,712.00p
13:30 2 @ 1,712.00p
13:30 25 @ 1,712.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page